Supplementary Figure S2 from Phase 2, Open-Label, Multicenter Study of Nelitolimod in Combination with Pembrolizumab in Anti–PD-1 Treatment-Naïve Advanced Melanoma
Authors:
- Antoni RibasARAntoni Ribas
- Mohammed M. MilhemMohammed M. Milhem
- Christopher J. HoimesCHChristopher J. Hoimes
- Asim AminAAAsim Amin
- Christopher D. LaoCLChristopher D. Lao
- Robert M. ConryRCRobert M. Conry
- Jason P. HuntJHJason P. Hunt
- Gregory A. DanielsGDGregory A. Daniels
- Mohammed AlmubarakMAMohammed Almubarak
- Montaser ShaheenMSMontaser Shaheen
- Theresa MedinaTMTheresa Medina
- Minal BarveMinal Barve
Open Access
- 1 October 2025
- other
- Published by American Association for Cancer Research (AACR)